P2RY12 and renal fibrosis: Chen et al. used the purinergic receptor type Y, subtype 12 (P2Y12) inhibitor clopidogrel to block the MMT process induced by P2Y12-mediated TGF-β/Smad3 pathway activation, and renal fibrosis in UUO mice was significantly inhibited [119].